Evidence map›Paper›PMID 41513735›Full record

ArticleScientific reports2026

The A2357T substitution in the kinase domain of yeast Tor1 confers growth promoting TORC1 activity independent of Gtr1/2 and Pib2.

Christopher Dereppe, Chloé Troch, Elie Saliba, Bruno André

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christopher DereppeMolecular Physiology of the Cell, Université Libre de Bruxelles (ULB), Biopark, Gosselies, Brussels, Belgium.
Chloé TrochMolecular Physiology of the Cell, Université Libre de Bruxelles (ULB), Biopark, Gosselies, Brussels, Belgium.
Elie SalibaMolecular Physiology of the Cell, Université Libre de Bruxelles (ULB), Biopark, Gosselies, Brussels, Belgium.
Bruno AndréMolecular Physiology of the Cell, Université Libre de Bruxelles (ULB), Biopark, Gosselies, Brussels, Belgium. bruno.andre@ulb.be.

Funding

Fonds De La Recherche Scientifique - FNRS 40014120
6 · The paper itself

Abstract

The highly conserved Target of Rapamycin Complex 1 (TORC1) plays a central role in controlling eukaryotic cell growth in response to diverse environmental cues, including nitrogen availability. In yeast, TORC1 activity is stimulated through direct interaction with at least two upstream regulators: the Gtr1/2 GTPase complex, homologous to mammalian RagAB/CD and which binds the fungus-specific Tco89 protein, and the FYVE-domain-containing protein Pib2, an amino acid sensor. Here, using a novel genetic approach, we first confirmed that in cells expressing neither Gtr1/2 nor Pib2, no other factor is capable of supporting sufficient TORC1 activity to sustain cell growth, even under 25 different nitrogen supply conditions. We then identified a novel, dominant TOR1 mutation introducing an A2357T substitution into the Tor1 kinase domain and conferring sufficient TORC1 activity to support cell growth despite the loss of both Gtr1/2 and Pib2. Interestingly, previous studies have identified substitutions at the corresponding A2420 residue in human mTOR from multiple cancer cells.

Indexed as

Amino Acid SubstitutionGTP-Binding ProteinsMechanistic Target of Rapamycin Complex 1Monomeric GTP-Binding ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsApoptosis Regulatory ProteinsPhosphatidylinositol 3-KinasesProtein DomainsTranscription FactorsApoptosis Regulatory ProteinsGTP-Binding ProteinsGtr1 protein, S cerevisiaeGTR2 protein, S cerevisiaeMechanistic Target of Rapamycin Complex 1Monomeric GTP-Binding ProteinsPhosphatidylinositol 3-KinasesPib2 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsTOR1 protein, S cerevisiaeTORC1 protein complex, S cerevisiaeTranscription FactorsKinaseRapamycinTORC1Yeast

Identifiers

PMID41513735
PMCPMC12864760

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.